Your browser doesn't support javascript.
loading
A novel complex neurological phenotype due to a homozygous mutation in FDX2.
Gurgel-Giannetti, Juliana; Lynch, David S; Paiva, Anderson Rodrigues Brandão de; Lucato, Leandro Tavares; Yamamoto, Guilherme; Thomsen, Christer; Basu, Somsuvro; Freua, Fernando; Giannetti, Alexandre Varella; de Assis, Bruno Della Ripa; Ribeiro, Mara Dell Ospedale; Barcelos, Isabella; Sayão Souza, Katiane; Monti, Fernanda; Melo, Uirá Souto; Amorim, Simone; Silva, Leonardo G L; Macedo-Souza, Lúcia Inês; Vianna-Morgante, Angela M; Hirano, Michio; Van der Knaap, Marjo S; Lill, Roland; Vainzof, Mariz; Oldfors, Anders; Houlden, Henry; Kok, Fernando.
Affiliation
  • Gurgel-Giannetti J; Department of Paediatrics, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Lynch DS; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK.
  • Paiva ARB; Leonard Wolfson Experimental Neurology Centre, UCL Institute of Neurology, London, UK.
  • Lucato LT; Neurogenetics Unit, Neurology Department, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil.
  • Yamamoto G; Neuroradiology Section, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil.
  • Thomsen C; Human Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brazil.
  • Basu S; Department of Pathology and Genetics, Sahlgrenska University Hospital, University of Gothenburg, Sweden.
  • Freua F; Institute for Cytobiology and Cytopathology, Philipps-Universität Marburg, Robert-Koch-Strasse 6, 35032 Marburg, Germany.
  • Giannetti AV; Neurogenetics Unit, Neurology Department, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil.
  • de Assis BDR; Department of Surgery, Federal University of Minas Gerais, Belo Horizonte, Brazil.
  • Ribeiro MDO; Neurogenetics Unit, Neurology Department, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil.
  • Barcelos I; Neurogenetics Unit, Neurology Department, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil.
  • Sayão Souza K; Neurogenetics Unit, Neurology Department, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil.
  • Monti F; Neurogenetics Unit, Neurology Department, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil.
  • Melo US; Neurogenetics Unit, Neurology Department, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil.
  • Amorim S; Human Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brazil.
  • Silva LGL; Neurogenetics Unit, Neurology Department, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil.
  • Macedo-Souza LI; Human Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brazil.
  • Vianna-Morgante AM; Human Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brazil.
  • Hirano M; Human Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brazil.
  • Van der Knaap MS; Department of Neurology, Columbia University Medical Center, New York, USA.
  • Lill R; Department of Child Neurology, VU University Medical Center, Amsterdam, The Netherlands.
  • Vainzof M; Institute for Cytobiology and Cytopathology, Philipps-Universität Marburg, Robert-Koch-Strasse 6, 35032 Marburg, Germany.
  • Oldfors A; LOEWE Center for Synthetic Microbiology, SynMikro, Hans-Meerwein-Strasse, 35043 Marburg, Germany.
  • Houlden H; Human Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brazil.
  • Kok F; Department of Pathology and Genetics, Sahlgrenska University Hospital, University of Gothenburg, Sweden.
Brain ; 141(8): 2289-2298, 2018 08 01.
Article in En | MEDLINE | ID: mdl-30010796
Defects in iron-sulphur [Fe-S] cluster biogenesis are increasingly recognized as causing neurological disease. Mutations in a number of genes that encode proteins involved in mitochondrial [Fe-S] protein assembly lead to complex neurological phenotypes. One class of proteins essential in the early cluster assembly are ferredoxins. FDX2 is ubiquitously expressed and is essential in the de novo formation of [2Fe-2S] clusters in humans. We describe and genetically define a novel complex neurological syndrome identified in two Brazilian families, with a novel homozygous mutation in FDX2. Patients were clinically evaluated, underwent MRI, nerve conduction studies, EMG and muscle biopsy. To define the genetic aetiology, a combination of homozygosity mapping and whole exome sequencing was performed. We identified six patients from two apparently unrelated families with autosomal recessive inheritance of a complex neurological phenotype involving optic atrophy and nystagmus developing by age 3, followed by myopathy and recurrent episodes of cramps, myalgia and muscle weakness in the first or second decade of life. Sensory-motor axonal neuropathy led to progressive distal weakness. MRI disclosed a reversible or partially reversible leukoencephalopathy. Muscle biopsy demonstrated an unusual pattern of regional succinate dehydrogenase and cytochrome c oxidase deficiency with iron accumulation. The phenotype was mapped in both families to the same homozygous missense mutation in FDX2 (c.431C > T, p.P144L). The deleterious effect of the mutation was validated by real-time reverse transcription polymerase chain reaction and western blot analysis, which demonstrated normal expression of FDX2 mRNA but severely reduced expression of FDX2 protein in muscle tissue. This study describes a novel complex neurological phenotype with unusual MRI and muscle biopsy features, conclusively mapped to a mutation in FDX2, which encodes a ubiquitously expressed mitochondrial ferredoxin essential for early [Fe-S] cluster biogenesis.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ferredoxins Limits: Adolescent / Adult / Child / Female / Humans / Male Country/Region as subject: America do sul / Brasil Language: En Journal: Brain Year: 2018 Document type: Article Affiliation country: Brazil Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ferredoxins Limits: Adolescent / Adult / Child / Female / Humans / Male Country/Region as subject: America do sul / Brasil Language: En Journal: Brain Year: 2018 Document type: Article Affiliation country: Brazil Country of publication: United kingdom